Hypervascular Tumors clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • Obsidio™ Conformable Embolic Registry

    open to eligible people ages 18 years and up

    OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio.

    Los Angeles, California and other locations

Our lead scientists for Hypervascular Tumors research studies include .

Last updated: